Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$0.75 - $0.95 $186 - $236
249 Added 2.14%
11,907 $8,000
Q4 2023

Jan 19, 2024

BUY
$0.7 - $1.33 $8,160 - $15,505
11,658 New
11,658 $11,000
Q2 2019

Jul 19, 2019

SELL
$7.58 - $10.0 $82,887 - $109,350
-10,935 Closed
0 $0
Q1 2019

Apr 24, 2019

BUY
$5.81 - $9.37 $4,194 - $6,765
722 Added 7.07%
10,935 $84,000
Q4 2018

Jan 23, 2019

SELL
$5.75 - $21.85 $9,056 - $34,413
-1,575 Reduced 13.36%
10,213 $66,000
Q3 2018

Oct 25, 2018

BUY
$16.81 - $24.58 $198,156 - $289,749
11,788 New
11,788 $265,000

Others Institutions Holding DBVT

About DBV Technologies S.A.


  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $745M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Jgp Global Gestao De Recursos Ltda. Portfolio

Follow Jgp Global Gestao De Recursos Ltda. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jgp Global Gestao De Recursos Ltda., based on Form 13F filings with the SEC.

News

Stay updated on Jgp Global Gestao De Recursos Ltda. with notifications on news.